A brief history of Agaricus blazei Murril mushroom

Agaricus blazei Murril was first noticed about 30 years ago when two researchers from Penn State University visited Piedade city, in Saint Paul state-Brazil and discovered that the natives were very healthy with very low rates of disease and that a disproportionately high number enjoyed longevity.

A Japanese-Brazilian farmer first discovered the Agaricus blazei Murril mushroom in the summer of 1965. Since 1968, Dr. Takashi Mizuno Ph.D., has studied the bioactive substances in fungi, especially those related to anti-tumor active polysaccharides.

They discovered that the Agaricus blazei Murril was rich in polysaccharide compounds, which assist in boosting the immune system. Research has found that the two principal polysaccharide compounds, which exist in Agaricus Blazei Murril, are ß(Beta) 1,3-D Glucan and ß(Beta) 1,6-D Glucan.

During the 1980's and 1990's scientists conducted studies that have shown the Agaricus blazei Murril mushroom to be an immune system stimulant which promotes the body's natural defense mechanisms to fight a variety of infectious agents, including cancer. The polysaccharide contained in Agaricus Blazei Murill vitalizes production of interferon and interleukin. This effect indirectly functions to destroy or prevent the proliferation of cancer cells. This refers to a cytosine inducing effect. Moreover, the experiments conducted by the researchers named above proved that this effect can also prevent viruses and other external factors from entering the tissue.

Clinical results, obtained in collaboration with university researchers and hospitals since the report on the anti-cancer effect of Agaricus blazei Murril  was released at the general convention of the Japan Cancer Association in 1980, proved that many fungi polysaccharides only effect solid cancer and the polysaccharide of Agaricus blazei Murril is effective against Ehrlich's ascites carcinoma, sigmond colonic cancer, ovarian cancer, breast cancer, lung cancer, and liver cancer, as well as against solid cancer.